Jim Cramer's top 10 things to watch in the stock market Wednesday

Market opened strongly on hopes of an Iran war resolution and a stronger-than-expected March ADP jobs signal ahead of Friday payrolls. Company-specific moves: RH missed key metrics and guided light with shares down ~18%; Nike beat revenue/EPS but issued weak guidance and drew downgrades from Goldman, JPMorgan and BofA. Analyst actions: Wells Fargo raised Arm PT to $175 from $165 (+$10) and initiated Boeing at buy with a $250 target (implying >25% upside); Wells cut Rockwell to $360 from $410 (-$50) and Eaton to $350 from $370 (-$20); KeyBanc cut Atlassian to $130 from $170 (-$40). Other notable calls: Constellation added to Evercore tactical buys, Edwards upgraded by Wolfe, and Sempra added to Wells Fargo tactical ideas.

Analysis

A de-escalation in the Middle East is behaving like a one-two punch: it removes an energy/insurance premium and simultaneously re-rates cyclicals whose earnings are more sensitive to volume than to multiple expansion. That said, industrial demand typically lags geopolitical relief by 2–6 months because OEM order books and supplier lead times have to re-fill; expect a phased recovery where aircraft production and heavy machinery show durable improvement only into late 2026.

A stronger-than-expected jobs signal ahead of NFP raises the odds the Fed stays higher for longer, which is a structural headwind for long-duration software multiples even if revenue growth holds. The likely regime is slower multiple expansion for SaaS — buyers will pay for earnings certainty rather than growth optionality — compressing names with weak ID’d competitive moats.

On specific franchises, Arm’s pivot into in-house silicon is a convex, multi-quarter optionality trade: wins with a Tier-1 hyperscaler would re-price the company materially, but adoption hinges on ecosystem validation (OS/toolchain, ISV optimization) over 6–12 months. Conversely, apparel/retail names with inventory overhangs are exposed to margin compression from promotional-driven clearance cycles and wholesale channel share losses, creating asymmetric downside into the next two quarters.

Catalysts to monitor: Friday’s NFP for policy direction, OEM factory utilization and backlog releases over the next 60–120 days, and discrete product/clinical readouts (Arm customer silicon wins; TAVR share data) that can flip sentiment quickly. Tail risks include renewed geopolitical flare-ups and a surprise inventory destocking wave that would reverse early cyclicals’ rally within 30–90 days.

Key Decisions for Investors

• Long ARM (ARM) — allocate 1.0% of book to equity or buy 12–18 month calls (target +30–50% if Arm secures 2+ data-center OEM wins). Hedge execution risk by sizing small; stop-loss at -25% and reassess on first hyperscaler design win or miss.
• Tactical long Boeing (BA) — 1.0% position via Jan‑2027 call spread (buy $220, sell $300) to capture FCF recovery as production normalizes. Anticipated ROI 20–40% if production cadence remains on plan; downside risk is certification/supplier disruption, cut position if monthly gross deliveries fall >15% vs run-rate.
• Short TEAM via put spread — buy 9–12 month put spread sized 0.5% of book (e.g., 2026 Sep 150/90) to play multiple contraction persisting despite modest ARR growth. Target 2–3x payoff if market re-rates SaaS multiples; max loss = premium paid (limited).
• Long Sempra (SREA) — 12–24 month buy with a 2% allocation to capture simplification/sale proceeds and regulated cash flows. Expect total return 15–25% plus yield; watch regulatory approvals and divestiture milestones, tighten if transaction terms slip >6 months.
• Consumer pair: short Nike (NKE) vs long Constellation Brands (STZ) — equal notional pair for 3–6 months to express inventory/brand risk vs resilient beverage demand. Objective: capture ~15–25% asymmetric move if footwear inventories force heavy promotions while beer revenues stabilize; use 20% stop on either leg.